PNO. Check prev posts.
Sydney - Thursday - July 21: (RWE Australian Business News) -
PharmaNet Group Ltd (ASX PNO) reports its pharmaceutical subsidiary
Molecular Pharmacology Ltd (MPL) has successfully synthesized a group of
candidate compounds that are believed to contain the Tripeptofen
molecule.
This achievement is a result of the efforts of MPL's scientific
team, working on the isolation and identification of the molecular
structures and biological processes responsible for Tripeptofen's
analgesic and anti-inflammatory properties.
MPL believes Tripeptofen to be a new type of pharmacological
agent that works in quite a distinct way from the anti-inflammatory
drugs involved in recent safety concerns and product withdrawals.
In total, ITC, PCP and PNO.
Do your own research.
the third and last minnow to follow
Add CAI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $101.9M | |||
| Open | High | Low | Value | Volume |
| 13.0¢ | 13.0¢ | 12.3¢ | $234.7K | 1.867M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 104875 | 12.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 1579409 | 18 |
View Market Depth
| Last trade - 15.43pm 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
12.5¢ |
Change
0.000 ( 1.96 %) |
||||
| Open | High | Low | Volume | ||
| 12.8¢ | 12.8¢ | 12.0¢ | 631180 | ||
| Last updated 15.40pm 17/05/2024 ? | |||||
| CAI (ASX) Chart |